Ihor Hospodarskyy

Ihor Hospodarskyy

Horbachevsky Ternopil State Medical University - Ternopil / Ukraine
Medical and Health Sciences / Gastroenterology
AD Scientific Index ID: 5053244
Хорбачевский государственный медицинский университет Тернопила
person_outline Ihor Hospodarskyy's MOST POPULAR ARTICLES
1-) Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial BG Feagan, S Danese, EV Loftus, S Vermeire, S Schreiber, T Ritter, ... The Lancet 397 (10292), 2372-2384, 2021 2092021
2-) Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials DT Rubin, I Dotan, A DuVall, Y Bouhnik, G Radford-Smith, PDR Higgins, ... The lancet Gastroenterology & hepatology 7 (1), 17-27, 2022 572022
3-) Long-term efficacy and safety of biosimilar CT-P10 versus innovator rituximab in rheumatoid arthritis: 48-week results from a randomized phase III trial CH Suh, DH Yoo, A Berrocal Kasay, E Chalouhi El-Khouri, ... BioDrugs 33, 79-91, 2019 312019
4-) A17 Efficacy and safety of filgotinib as maintenance therapy for patients with moderately to severely active ulcerative colitis: results from the phase 2B/3 SELECTION studyL Peyrin-Biroulet, EV Loftus Jr, S Danese, S Vermeire, WJ Sandborn, ...Journal of the Canadian Association of Gastroenterology 4 (Suppl 1), 21, 2021152021
5-) Pharmacokinetics and safety of three formulations of rituximab (CT-P10, US-sourced innovator rituximab and EU-sourced innovator rituximab) in patients with rheumatoid arthritis …CH Suh, A Berrocal Kasay, E Chalouhi El-Khouri, P Miranda, ...2016 ACR/ARHP Annual Meeting, 2016142016